CANbridge Pharmaceuticals' (HKG:1228) Massachusetts subsidiary CANbridge Pharmaceuticals terminated a property lease with landlord MEC Burlington Woods Biocenter, a Tuesday filing said.
The property comprises office and laboratory space in a building at 4 Burlington Woods Drive, Burlington, Massachusetts, which the group leased in December 2021.
The early termination is part of the group's downsizing plan for its US business and does not result in a penalty or fee.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.